diabetes

Special Indian pharma launches low-cost Ozempic generics as patent expires

Indian pharma launches low-cost Ozempic generics as patent expires

  • Novo Nordisk’s patent protections for semaglutide expired on March 20
  • Generics were available for order at Indian pharmacies the next day
By Sanjay Kumar ·

Special SCAI developing AI technology to predict diabetes, reveals top official video

SCAI developing AI technology to predict diabetes, reveals top official

By Reina Takla - Nirmal Narayanan  ·

Health minister: 11 million Egyptians have diabetes

Health minister: 11 million Egyptians have diabetes

By Gobran Mohammed ·